Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Amedisys Inc. (AMED)

117.1 0.7 (0.6%)

11-14 16:00

Open:

116.84

Pre. Close:

116.4

High:

117.7756

Low:

115.82

Volume:

269,231

Market Cap:

3734M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

117.839 - 118.42

118.42 - 119.008

Low:

114.445 - 115.051

115.051 - 115.666

Close:

116.128 - 117.086

117.086 - 118.057

Technical analysis  (as of: 2018-11-14 4:29:47 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 143.31     One year: 167.39

Support:

Support1: 107.05    Support2: 97.38

Resistance:

Resistance1: 122.70    Resistance2: 143.31

Pivot:

112.37

Moving Averages:

MA(5): 118.05     MA(20): 111.49

MA(100): 110.25     MA(250): 81.65

MACD:

MACD(12,26): 1.07     Signal(12,26,9): -0.14

%K %D:

%K(14,3): 77.12     %D(3): 82.76

RSI:

RSI(14): 54.28

52-Week:

High: 127.38  Low: 49.8  Change(%): 109.7

Average Vol(K):

3-Month: 45529  10-Days 62926

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
AMED has closed below upper band by 31.1%. Bollinger Bands are 71% wider than normal. The large width of the bands suggest high volatility as compared to AMED's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

2018-10-30T17:18:09-04:00
Amedisys, Inc. (AMED) CEO Paul Kusserow on Q3 2018 Results - Earnings Call Transcript

2018-10-30T14:32:46-04:00
AMEDISYS Inc 2018 Q3 - Results - Earnings Call Slides

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Care

Shares Out. (M)

31.89

Shares Float (M)

29.13

% Held by Insiders

8.70

% Held by Institutions

163.90

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

3.300

EPS Est. Current Year

2.210

EPS Est. Next Year

2.440

EPS Est. Next Quarter

0.580

Forward EPS

3.299

Book Value (p.s.)

8.550

PEG Ratio

1.64

Profit Margin

5.43

Operating Margin

8.60

Return on Assets (ttm)

11.5

Return on Equity (ttm)

18.4

Qtrly Rev. Growth

9.8

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

647.60

Operating Cash Flow (M)

133.36

Levered Free Cash Flow (M)

94.17

Valuation

P/E

35.48

P/E Growth Ratio

0.01

P/BV

13.70

P/S

79861392.00

P/CF

28.00

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.